These results indicate that APG-1387-stimulated release of IFN-γ, IL-5, IL-12p70, and TNF-α from the tumor were necessary but not sufficient for the synergistic effect between APG-1387 and anti-PD-1 antibody. The gene discussed is IL5; the disease is neoplasm.